Cargando…

Bofutsushosan Significantly Ameliorated Betamethasone-Induced Cushing’s Syndrome

Detalles Bibliográficos
Autor principal:	Yanai, Hidekatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031253/ https://www.ncbi.nlm.nih.gov/pubmed/29977426 http://dx.doi.org/10.14740/jocmr3483w

Ejemplares similares

A Significance of High Prevalence of Diabetes and Hypertension in Severe COVID-19 Patients
por: Yanai, Hidekatsu
Publicado: (2020)

Significant Correlations of SARS-CoV-2 Infection With Prevalence of Overweight/Obesity and Mean Body Mass Index in the SARS-CoV-2 Endemic Countries
por: Yanai, Hidekatsu
Publicado: (2020)

Drug-induced cystitis caused by herbal medicine (Bofutsushosan)
por: Kato, Kumiko, et al.
Publicado: (2021)

Adiposity is the Crucial Enhancer of COVID-19
por: Yanai, Hidekatsu
Publicado: (2020)

Acute Effects of Preventing Heart Failure by Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu
Publicado: (2021)

Cushing's Syndrome and Treatment-Resistant Depression
por: Shukla, Lekhansh
Publicado: (2017)

A difficult to treat case of Cushing's syndrome
por: Garg, M. K., et al.
Publicado: (2013)

Which Nutritional Factors Are Good for HDL?
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

A Different Effect of an Orexin Receptor Antagonist on Metabolic Parameters Between Diabetic Patients and Non-Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

An Influence of the Estimated Glomerular Filtration Rate on Improvement in Metabolic Parameters by Sodium-Glucose Cotransporter 2 Inhibitors
por: Katsuyama, Hisayuki, et al.
Publicado: (2016)

A Possible Mechanism for Renoprotective Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Elevation of Erythropoietin Production
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

Does Metformin Assist New Anti-Diabetic Drugs to Succeed?
por: Kastuyama, Hisayuki, et al.
Publicado: (2019)

A Possible Exquisite Crosstalk of Urate Transporter 1 With Other Urate Transporters for Chronic Kidney Disease and Cardiovascular Disease Induced by Dotinurad
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Severe Hypercortisolism with Hypokalemic Alkalosis Mimicking Ectopic Cushing Syndrome in a Patient with Cushing Disease Due to Pituitary Microadenoma
por: Goyal, Alpesh, et al.
Publicado: (2018)

Intravenous Immunoglobulin Therapy for Persistent Pemphigoid Gestationis with Steroid Induced Iatrogenic Cushing's Syndrome
por: Ko, Bum Joon, et al.
Publicado: (2014)

Habit of Bathing or Showering Is Beneficially Associated With Body Weight and Abdominal Circumference in Patients With Type 2 Diabetes
por: Katsuyama, Hisayuki, et al.
Publicado: (2018)

Which Factor Determines the Duration Required for Relief of Glucotoxicity by the Intensive Insulin Therapy?
por: Yanai, Hidekatsu, et al.
Publicado: (2018)

The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4
por: Koguchi, Ayako, et al.
Publicado: (2017)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

What Properties of Sodium-Glucose Cotransporter 2 Inhibitors Determine the Improvement in Hemoglobin A1c and Body Weight?
por: Yanai, Hidekatsu, et al.
Publicado: (2017)

The Possible Mechanisms for Improvement of Liver Function due to Sodium-Glucose Cotransporter-2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Inhibitory effect of Bofutsushosan (Fangfengtongshengsan) extract on the absorption of fructose in rats and mice
por: Takagi, Kohei, et al.
Publicado: (2023)

An epidemic of iatrogenic Cushing's syndrome in anticipation in post-COVID era
por: Chatterjee, Subhankar, et al.
Publicado: (2022)

Concomitant systemic inflammation and cellular immunosuppression in patients with Cushing's syndrome
por: van Houten, Pepijn, et al.
Publicado: (2023)

A Case of Iatrogenic Cushing Syndrome Secondary to Application of Topical Corticosteroids
por: Sardesai, Vidyadhar R., et al.
Publicado: (2019)

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome
por: Barbot, Mattia, et al.
Publicado: (2020)

An Effective Insulin Therapy in Combination With Sodium-Glucose Cotransporter 2 Inhibitors
por: Yanai, Hidekatsu, et al.
Publicado: (2019)

Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2023)

Intralesional betamethasone as a therapeutic option for alopecia areata
por: Melo, Daniel Fernandes, et al.
Publicado: (2018)

Aldosterone- and cortisol-co-producing adrenal adenoma without clinical features of Cushing syndrome
por: Chang, Kyung Yoon, et al.
Publicado: (2014)

CUSHING'S SYNDROME CAUSED BY AN ADRENOCORTICAL CARCINOMA AFTER A BARIATRIC SURGERY: CASE REPORT
por: SOUTO, Kátia Elisabete Pires, et al.
Publicado: (2015)

Diagnosis of cyclic Cushing syndrome using the morning urine free cortisol to creatinine ratio
por: Jang, Yi Sun, et al.
Publicado: (2016)

Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
por: Ono, Masafumi, et al.
Publicado: (2013)

Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice
por: Kobayashi, Shinjiro, et al.
Publicado: (2017)

Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone
por: Dow, Adrienne, et al.
Publicado: (2013)

Difficult central venous cannulation in Cushing's syndrome: Ultrasound-guided brachiocephalic vein cannulation to the rescue
por: Kumari, Poonam, et al.
Publicado: (2020)

Cavity in lung in a case of Cushing's disease
por: Kharb, Sandeep, et al.
Publicado: (2011)

Understanding of Diabetic Dyslipidemia by Using the Anion-Exchange High Performance Liquid Chromatography Data
por: Yanai, Hidekatsu, et al.
Publicado: (2016)

Streptococcal Infection Can Be the Trigger for Thyroid Storm
por: Hakoshima, Mariko, et al.
Publicado: (2019)

Low DHEAS Level: A Surrogate Marker of Adrenal Cushing Syndrome with Grey Zone ACTH Levels
por: Dhar, Abhranil, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1b4f31dcbdf5c96ie9it6ig7gh